Event: 2023 American Society of Clinical Oncology Meeting (Chicago)
Follow Our Progress
Preclinical development of RAG1-40-31L: A novel small activating RNA-lipid conjugate targeting tumor suppressor gene p21 for treatment of non-muscle invasive bladder cancer. (Abstract)
PUBLICATIONS & PRESENTATIONS